Symposia Abstracts
MS5 - The innovation of targeted therapy in the treatment of Hodgkin Lymphoma and sALCL (Systemic Anaplastic Large Cell Lymphoma)
| BRENTUXIMAB VEDOTIN: PHARMACOLOGY AND PHARMACOKINETICS Danesi R. |
| CD 30+ HEMATOLOGIC MALIGNANCIES: THE IMPORTANCE OF AN APPROPRIATE DIAGNOSIS Pileri S. |